Efficacy Safety and Tolerability of Multiple Doses of Oshadi Icp (Oshadi Oral Insulin) in Patients With Type 1 Diabetes Mellitus - Phase II Clinical Study
PHASE2CompletedINTERVENTIONAL
Enrollment
12
Participants
Timeline
Start Date
December 31, 2013
Primary Completion Date
February 28, 2017
Study Completion Date
February 28, 2017
Conditions
Diabetes MellitusInsulin-DependentType 1
Interventions
DRUG
Oshadi Icp
Trial Locations (1)
Unknown
Assaf-Harofeh Medical Center, Ẕerifin
All Listed Sponsors
lead
Oshadi Drug Administration
INDUSTRY
NCT01973920 - Efficacy Safety and Tolerability of Multiple Doses of Oshadi Icp (Oshadi Oral Insulin) in Patients With Type 1 Diabetes Mellitus - Phase II Clinical Study | Biotech Hunter | Biotech Hunter